RollingStone Co

RollingStone Co Interest Coverage

The Interest Coverage Ratio of RollingStone Co (214610.KQ) as of Oct 30, 2026 is -3.32. In the previous year, Interest Coverage Ratio was -2.79 — a change of 18.97% (lower).

Interest Coverage

-3.32

YoY

18.97%

Last updated:

Interest Coverage Ratio of RollingStone Co is 2024 -3.32 . Interest Coverage Ratio of RollingStone Co was 2023 -2.79 . It decreases by 18.97% lower compared to the previous year.

The RollingStone Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
-33.47 KRW
Jan 1, 2018
-16.13 KRW
Jan 1, 2019
-15.63 KRW
Jan 1, 2020
0.36 KRW
Jan 1, 2021
-205.76 KRW
Jan 1, 2022
-2.32 KRW
Jan 1, 2023
-2.79 KRW
Jan 1, 2024
-3.32 KRW
The RollingStone Co Interest Coverage history
YEARInterest CoverageYoY
-3.32+18.97%
-2.79+20.62%
-2.32-98.87%
-205.76-56,542.64%
0.36-102.33%
-15.63-3.09%
-16.13-51.81%
-33.47-75.92%
-138.99+13,204.80%
-1.04-81.54%
-5.66—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RollingStone Co Stock analysis

What does RollingStone Co do? MiCo BioMed Co. Ltd. generates revenue through three business segments. The Molecular Diagnosis segment sells nucleic acid extraction equipment, gene amplification equipment, reagents, and lab chips. The Biochemical Diagnosis segment supplies complex diagnostics, anemia meters, blood glucose meters, medical devices, and strips. The Immunodiagnostic Business segment produces and sells immunodiagnostic devices and immunodiagnostic kits. These products are sold to healthcare providers and medical facilities that require diagnostic tools for patient testing and analysis. The company's products target healthcare institutions including hospitals and clinics. Medical professionals use these devices for accurate diagnosis and treatment planning. The Biochemical Diagnosis segment's blood glucose meters and anemia meters are particularly used in point-of-care testing environments. The Molecular Diagnosis segment's gene amplification equipment supports laboratory-based genetic testing procedures. MiCo BioMed's business model focuses on direct sales to medical institutions and healthcare providers. The company does not mention any third-party distributors or online sales channels. Its product portfolio serves both hospital laboratories and outpatient diagnostic centers. The Immunodiagnostic Business segment's kits are designed for rapid testing applications in clinical settings. RollingStone Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RollingStone Co stock

Interest Coverage Ratio of RollingStone Co is -3.32 in 2024.

Interest Coverage Ratio of RollingStone Co changed from -2.79 to -3.32, representing a 18.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio RollingStone Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's RollingStone Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — RollingStone Co

All Key Metrics — RollingStone Co